advertisement
Your Special Attention For IGR 11-3
Advances in telemetric continuous intraocular pressure assessment
Kakaday T, Hewitt AW, Voelcker NH, Li JS, Craig JEBritish Journal of Ophthalmology 2009; 93: 992-996
Abstract no. 1049
Continuous and 24 hour measurement of IOP is an unmet need for glaucoma management.
Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients
Saglar E, Yucel D, Bozkurt B, Ozgul RK, Irkec M, Ogus AMolecular Vision 2009; 15 1270-1276
Abstract no. 1015
Genetics genetics is beginning to be elucidated.
Gene therapy targeting glaucoma: where are we?
Liu X, Rasmussen CA, Gabelt BT, Brandt CR, Kaufman PLSurvey of Ophthalmology 2009; 54: 472-486
Abstract no. 1243
After controversial early testing, gene therapy offers considerable therapeutic potential.
Glaucoma: an area of darkness
Hitchings RA.Eye 2009; 23: 1764-1774
Abstract no. 1055
Glaucoma management provides daunting challenges.
Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions
Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JDJournal of Opioid Management 2009; 5: 153-168
Abstract no. 1256
Is medical use of marijuana appropriate to treat glaucoma and other medical conditions?
Self-tonometry in glaucoma management--past, present and future
Liang SY, Lee GA, Shields DSurvey of Ophthalmology 2009 Jul-; 54: 450-462
Abstract no. 895
Self-tonometry is promising, but still has not gained favor for the management of glaucoma.
The estimation of approximate sample size requirements necessary for clinical and epidemiological studies in vision sciences
Goodall EA, Moore J, Moore TEye 2009; 23: 1589-1597
Abstract no. 1343
Sample size calculations are critical for clinicial studies of glaucoma.
